NIHR BioResource and Congenica Finalists for Bio-IT World 2017 Best Practices Award
NIHR BioResource and Congenica Finalists for Bio-IT World 2017 Best Practices Award
Bridging the Gap: Overcoming the Bottleneck of Variant Interpretation
Bridging the Gap: Overcoming the Bottleneck of Variant Interpretation
Congenica completes Series B financing round with investments from China-based BGI, Healthlink and Future Planet
Congenica completes Series B financing round with investments from China-based BGI, Healthlink and Future Planet
Congenica and Edico Genome Partner to Speed Analysis from ‘DNA to Diagnosis’ for Inherited Diseases
Congenica and Edico Genome Partner to Speed Analysis from ‘DNA to Diagnosis’ for Inherited Diseases
Congenica raises £8M ($10M) in Series B financing round to drive international expansion of its genome analysis business
Congenica raises £8M ($10M) in Series B financing round to drive international expansion of its genome analysis business
Whole Genome Analysis Leads To Faster Diagnosis And Cost Benefits
Whole Genome Analysis Leads To Faster Diagnosis And Cost Benefits
Congenica Expands in North America with Strategic Appointment
Congenica Expands in North America with Strategic Appointment
Roundtable Discussion: Taking Whole Genome Sequencing Mainstream
Roundtable Discussion: Taking Whole Genome Sequencing Mainstream
Elucigene partners with Congenica on new NGS cystic fibrosis kit
Elucigene partners with Congenica on new NGS cystic fibrosis kit
Sapientia helps manage ten-fold increase in demand for genomic analysis
Sapientia helps manage ten-fold increase in demand for genomic analysis
Congenica Detecting Clinically Relevant Variants In 35% Of First Diagnostic Reports Delivered To UK 100,000 Genomes Project
Sapientia Detecting Clinically Relevant Variants In 35% Of First Diagnostic Reports Delivered To UK 100,000 Genomes Project
Consistency and data sharing vital to unlock value of genetic testing says Congenica’s Dr Matthew Hurles
Consistency and data sharing vital to unlock value of genetic testing says Congenica’s Dr Matthew Hurles